Cargando…

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis

PURPOSE: This study aimed to screen differentially expressed proteins (DEPs) in plasma of patients with sepsis through data-independent acquisition (DIA) and enzyme-linked immunosorbent assays (ELISAs), and provide convenient and accurate serum markers for determining the condition of septic patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Meiyan, Zhang, Qian, Hu, Yingchun, Sun, Changfeng, Sheng, Yunjian, Deng, Cunliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318715/ https://www.ncbi.nlm.nih.gov/pubmed/34335032 http://dx.doi.org/10.2147/IDR.S316402

Ejemplares similares

Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2013)

Prognostic relevance of LGALS3BP in human colorectal carcinoma
por: Piccolo, Enza, et al.
Publicado: (2015)

AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics
por: Liu, Xiaoling, et al.
Publicado: (2021)

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific
por: Lodermeyer, Veronika, et al.
Publicado: (2018)

Investigational drugs with dual activity against HBV and HIV (Review)
por: Sun, Shiyu, et al.
Publicado: (2021)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
por: Capone, Emily, et al.
Publicado: (2020)

Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases
por: Costa, Júlia, et al.
Publicado: (2020)

Extracellular LGALS3BP regulates neural progenitor position and relates to human cortical complexity
por: Kyrousi, Christina, et al.
Publicado: (2021)

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
por: Dufrusine, Beatrice, et al.
Publicado: (2023)

THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
por: Ding, Yuxi, et al.
Publicado: (2022)

LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia
por: Zhao, Chenyang, et al.
Publicado: (2022)

Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma
por: Wu, Meei-Maan, et al.
Publicado: (2017)

Association of toll-like receptor polymorphisms with acquisition of HIV infection and clinical findings: A protocol for systematic review and meta-analysis
por: Shi, Han, et al.
Publicado: (2020)

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling
por: Cho, Sang-Hee, et al.
Publicado: (2021)

Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex
por: Xu, Gang, et al.
Publicado: (2019)

Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis
por: Shi, Han, et al.
Publicado: (2019)

Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer
por: Fan, Yue, et al.
Publicado: (2020)

Data-independent acquisition-based mass spectrometry(DIA-MS) for quantitative analysis of patients with chronic hepatitis B
por: Wang, Bo, et al.
Publicado: (2023)

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
por: Bosquillon de Jarcy, Laure, et al.
Publicado: (2023)

Potential Biomarkers for Early Diagnosis, Evaluation, and Prognosis of Sepsis-Induced Coagulopathy
por: Li, Yuting, et al.
Publicado: (2023)

Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population
por: Singh, Prerana, et al.
Publicado: (2020)

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis
por: Sun, Eun-Gene, et al.
Publicado: (2023)

Upregulation of LGALS1 is associated with oral cancer metastasis
por: Li, Ji-Min, et al.
Publicado: (2018)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme
por: Takashima, Yasuo, et al.
Publicado: (2019)

Platelet‑related parameters as potential biomarkers for the prognosis of sepsis
por: Zhang, Chao, et al.
Publicado: (2023)

A study on biomarkers of sepsis and potential role of procalcitonin and ferritin marker in diagnosis, prognosis and treatment
por: Samuel, Marcella Sherin, et al.
Publicado: (2022)

iTRAQ-based proteomic analysis of endotoxin tolerance induced by lipopolysaccharide
por: Zhang, Qian, et al.
Publicado: (2019)

Potential biomarker for diagnosis and therapy of sepsis: Lactylation
por: Sun, ZeXian, et al.
Publicado: (2023)

A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
por: Feng, Yan, et al.
Publicado: (2023)

SREBP1 regulates Lgals3 activation in response to cholesterol loading
por: Li, Jing, et al.
Publicado: (2022)

LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
por: Li, Xuejian, et al.
Publicado: (2023)

Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock
por: Lee, Jae Ha, et al.
Publicado: (2022)

VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis
por: Guan, Wei, et al.
Publicado: (2023)

Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis
por: Guo, Kaixuan, et al.
Publicado: (2023)

Serum NF-κBp65, TLR4 as Biomarker for Diagnosis of Preeclampsia
por: Litang, Zhao, et al.
Publicado: (2017)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Enhanced cortical bone expansion in Lgals3-deficient mice during aging
por: Maupin, Kevin A., et al.
Publicado: (2018)

Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021)

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
por: Lv, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5nuqfh8dhgkd68t86b8ip88u1